Continued cost recovery is the aim of proposed medtech user fee rises by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The hikes would take effect in April 2025.
A seven-week consultation closing 24 October allows stakeholders to give their views on what one regulatory specialist, commenting on social...